6431.TW TAI
Kuangli Bio-Tech Holdings Co., Ltd.
1W: -2.3%
1M: -13.0%
3M: -13.0%
YTD: -34.7%
1Y: +8.6%
3Y: -11.7%
5Y: -49.3%
NT$16.90 ($0.53)
-0.15 (-0.88%)
Weekly Expected Move ±4.1%
NT$16
NT$16
NT$17
NT$18
NT$18
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$1.2B
+30.4% ▲
5Y CAGR: +25.7%
Total Liabilities
$607M
+34.8% ▲
5Y CAGR: +56.7%
Shareholders Equity
$577M
+25.5% ▲
5Y CAGR: +13.0%
Cash & Investments
$310M
+645.9% ▲
5Y CAGR: +22.1%
Total Debt
$487M
+44.7% ▲
5Y CAGR: +130.1%
Net Debt
$278M
-5.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $162M | $142M | $63M | $42M | $209M |
| Short-Term Investments | $21M | $21M | $28M | $0 | $101M |
| Cash & ST Investments | $183M | $163M | $91M | $42M | $310M |
| Net Receivables | $231M | $163M | $136M | $115M | $82M |
| Inventory | $97M | $63M | $58M | $57M | $47M |
| Other Current Assets | $0 | $0 | $217K | $4M | $4M |
| Total Current Assets | $523M | $400M | $306M | $249M | $464M |
| Property, Plant & Equip. | $379M | $364M | $381M | $320M | $419M |
| Goodwill & Intangibles | $342M | $330M | $298M | $273M | $245M |
| Long-Term Investments | $0 | $0 | $11M | $8M | $8M |
| Other Non-Current Assets | $3M | $6M | $13M | $14M | $6M |
| Total Non-Current Assets | $726M | $716M | $738M | $661M | $723M |
| Total Assets | $1.2B | $1.1B | $1.0B | $910M | $1.2B |
| — Liabilities — | |||||
| Accounts Payable | $95M | $30M | $22M | $57M | $49M |
| Short-Term Debt | $148M | $158M | $189M | $164M | $184M |
| Deferred Revenue | $60M | $13M | $0 | $0 | $0 |
| Other Current Liabilities | $32M | $35M | $28M | $54M | $33M |
| Total Current Liabilities | $328M | $273M | $283M | $308M | $342M |
| Long-Term Debt | $0 | $12M | $21M | $6M | $6M |
| Other Non-Current Liab. | $2M | $0 | $2M | $3M | $2M |
| Total Non-Current Liabilities | $178M | $170M | $202M | $142M | $265M |
| Total Liabilities | $507M | $443M | $485M | $450M | $607M |
| — Equity — | |||||
| Common Stock | $512M | $572M | $572M | $724M | $974M |
| Retained Earnings | -$243M | -$168M | -$272M | -$445M | -$638M |
| Accumulated OCI | -$38M | -$32M | $0 | -$23M | -$34M |
| Total Stockholders Equity | $482M | $673M | $558M | $460M | $577M |
| Total Liabilities & Equity | $1.2B | $1.1B | $1.0B | $910M | $1.2B |
| — Key Metrics — | |||||
| Total Debt | $348M | $350M | $422M | $337M | $487M |
| Net Debt | $186M | $208M | $358M | $295M | $278M |
| Total Investments | $21M | $21M | $39M | $8M | $8M |